ReviewJournal of thoracic disease2026
Research advances in consistency and variability in
Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ex vivo lung perfusion (EVLP) has become an important platform for dynamic assessment and preservation of donor lungs, particularly for marginal grafts that might otherwise be declined for transplantation. Although EVLP has expanded the donor lung pool and improved opportunities for graft selection, the lack of standardized assessment criteria remains a major barrier to its broader clinical application. Considerable variability persists across centers, device platforms, perfusate compositions, perfusion flows, ventilation strategies, sampling time points, and thresholds used to determine transplant suitability. This review summarizes current evidence on the consistency and variability of EVLP assessment metrics, with emphasis on physiological parameters, ventilatory mechanics, hemodynamic indices, edema evaluation, biochemical and inflammatory biomarkers, microbiological assessment, imaging findings, and composite scoring systems. Core metrics such as the PaO
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.